Study of Lower Extremity Ischemia During PCPS Support

• Published in: Jinko Zoki Vol. 29; no. 2; pp. 345 - 350
• Main Authors: Satou, M, Endou, H, Fujiki, T, Ide, H, Sudou, K
• Format: Journal Article
• Language: Japanese
• Published: JAPANESE SOCIETY FOR ARTIFICIAL ORGANS 2000; 一般社団法人 日本人工臓器学会
• Subjects: Lower extremity ischemia; PCPS
• ISSN: 0300-0818; 1883-6097
• DOI: 10.11392/jsao1972.29.345

Although percutaneous cardioplumonary support (PCPS) is effective as an emergency measure for circulatory collapse, lower extremity ischemia and myonephrotic metabolic syndrome is still considered to be its major lethal side effect. Twenty-six consecutive patients who necessitated PCPS support were enrolled in this study. Seven patients (27%) were found clinically to have lower extremity ischemia of the cannulated side, of whom two patients died of myonephro metabolic syndrome. Regard' to their basal disease, 50% of the patients with ischemic heart disease are shown to have lower extremity ischemia, and 7% of those are without ischemic heart disease, showing a significant difference. As for plasma enzymal analysis, plasma CPK level is shown to be a significant index for exclusively evaluating lower extremity ischemia. Concomitant extremity perfusion of the PCPS cannulated side using a 14G needle is found to be effective for preventing lower extremity ischemia.